Pharmicell Co., Ltd. (KRX:005690)

Pharmicell Revenue

Pharmicell had revenue of 3.65B KRW in the quarter ending June 30, 2014, a decrease of -58.16%. This brings the company's total for the last twelve months to 23.94B, down -3.60% year-over-year. In the year 2013, Pharmicell had annual revenue of 33.41B with 200.63% growth. That makes Pharmicell the 34,434th largest company in the world by revenue and 2,202nd in South Korea.

• Revenue (ttm): 23.94B
• Revenue Growth: -3.60%
• P/S Ratio: 23.56
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 570.04B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Chemical Business Department 21.30B 63.8%
• Bio Business Department 12.10B 36.2%

By Geography

Chart

• South Korea 26.39B 79.0%
• Europe 3.86B 11.6%
• United States 2.80B 8.4%
• Asia 359.78M 1.1%

Fiscal year ended Dec 31, 2013

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2013	33.41B	22.29B	200.63%
Dec 31, 2012	11.11B	829.38M	8.07%
Dec 31, 2011	10.28B	3.07B	42.47%
Dec 31, 2010	7.22B	28.94M	0.40%
Dec 31, 2009	7.19B	-1.14B	-13.68%

Data Source: S&P Global Market Intelligence Last updated: Aug 29, 2014

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error